SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-282686
Filing Date
2018-09-25
Accepted
2018-09-25 17:31:23
Documents
4
Effectiveness Date
2018-09-25

Document Format Files

Seq Description Document Type Size
1 S-8 d624002ds8.htm S-8 67171
2 EX-5.1 d624002dex51.htm EX-5.1 6873
3 EX-23.1 d624002dex231.htm EX-23.1 1545
4 GRAPHIC g624002g0924204847466.jpg GRAPHIC 2502
  Complete submission text file 0001193125-18-282686.txt   80403
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-227525 | Film No.: 181086441
SIC: 3826 Laboratory Analytical Instruments